 After starting the week ended March 28 on the backfoot, biotech stocks recovered through the week. Activity in the space remained light, although coronavirus COVID-19 news flow continued to dominate.Here are the key catalysts that may impact biotech stocks in the unfolding week.Conferences Most conferences 